+ Part I · The question
What touches what, and for how long.
Biocompatibility sounds like a property a material has, but it is a judgment about a device in a use. The same plastic can be safe in one product and harmful in another, because the outcome depends on what the material touches, the route by which anything it releases enters the body, how long the contact lasts and which patient it meets. Chapter 1 defines the word, separates a hazard from a risk and sets out the chain this book follows, from the material to the body's response. It also introduces the home breathing machine designed in the chapters. Chapter 2 sorts that machine's contacts by tissue and by duration, as the standards for biological evaluation do.
Not a property of the material.
+ The questionWhy can one plastic be safe in a water bottle and a hazard in a breathing circuit?
One plastic, three uses
A drinking-water bottle of PET, a breathing-machine hose of thermoplastic elastomer and a blood bag of flexible PVC are three plastics in three uses, and what each releases reaches the body in a different way. The bottle holds water at room temperature, and whatever the water takes from the wall is swallowed and passes through the gut before it reaches the blood. The hose carries warm, humid air to a sleeping patient's nose for hours each night, so whatever it gives to that air is breathed onto the airway and into the lungs. The bag holds blood components for up to 6 weeks after collection, and at transfusion whatever the blood took from the plastic enters the circulation directly (Chapter 4).
Suppose one plastic, with the same chains and the same additives, were made into all three. Its chemistry would be the same in each. The outcome would still differ, because four things change with the use: the contact, the route, the duration and the patient. The contact decides what leaves the plastic: water draws little of a fat-loving additive, blood draws more, and air takes only what evaporates (Chapter 4). The route decides which tissue meets what leaves: the lining of the gut, the airway or the blood itself. The duration decides how long the release goes on: a drink, night after night of use, or weeks of storage. The patient differs as well, and the last section takes up what body mass does to the dose.
A material that suits a bottle can therefore carry a risk in a breathing circuit without any change to the material. Until the use is named, the question "Is this plastic biocompatible?" has no answer. The definition of the word makes the use part of its meaning.
An appropriate response in a specific application
Biocompatibility is "the ability of a material to perform with an appropriate host response in a specific application". In the definition, the host is the patient's body, to perform is to do the device's job, and the specific application is the device with its contact and duration. The wording comes from a consensus conference of the European Society for Biomaterials in Chester, and Williams, a biomaterials scientist, published its definitions. Williams quotes the definition in his 2019 review, which dates the conference proceedings to 1986. The review also states that the definition "was confirmed as still correct" in a 2018 paper by Zhang and Williams.
The definition asks for an appropriate response, not for none, because the body responds to whatever it touches, beginning with the proteins that coat a surface (Chapter 8). The question is whether the response suits the use: a mask cushion has to seal against the face while the skin under it stays healthy, and a blood bag has to leave the blood fit to transfuse. Williams states the consequence in the same review: "biocompatibility is not a property of a biomaterial, but of a biomaterial-host system". He adds that the definition "does not, indeed cannot, tell us how to design a material".
The standard and the regulator both place the judgment on the device rather than on its materials. ISO 10993-1 is the standard for the biological evaluation of devices. Its 2025 edition states that biological evaluation "is synonymous with biocompatibility evaluation" and calls it "an exercise in risk management". FDA's guidance on the standard dates from 2023, before that edition, and states that the agency "does not clear or approve individual materials that are used in the fabrication of medical devices". FDA's page on the basics of biocompatibility adds that the agency "assesses the biocompatibility of the whole device and not just the component materials".
The device is judged because its material changes on the way to the patient and again in use. FDA's guidance notes that "manufacturing and processing could affect the final chemistry presented to the body". A supplier's data filed with the agency therefore "may not be sufficient to establish the biocompatibility of the device" on their own. The guidance adds that the risk assessment should evaluate the final finished device, with its manufacturing methods, its sterilization and any residues of the aids used to make it (Chapters 3, 6 and 7). Use can then change the material while its name stays the same, and the judgment changes with it. The risk assessment quoted in the opening found the degraded foam not biocompatible, and it made no such finding about polyurethane in general (Chapters 5 and 20).
A hazard needs a route and a dose
ISO 14971:2019 is the standard for risk management of medical devices, and it gives the word "hazard" a precise sense. It defines a hazard as a "potential source of harm" and harm as "injury or damage to the health of people, or damage to property or the environment", in the wording that FDA's guidance on human factors reproduces. In this sense an additive in a plastic is a hazard if some amount of it can injure. A fragment that can break off is another, and so is a surface on which blood clots. Between each of them and harm stand two conditions: what the material offers must reach tissue, and it must arrive in an amount that the tissue cannot tolerate.
The first condition is the route, the path by which a substance reaches the body: through the skin, onto the airway or into the blood. In ISO 14971, a hazardous situation is a circumstance in which people, property or the environment are exposed to one or more hazards. Chapter 22 follows the standard's chain from hazard to harm. The second condition is the dose, the amount that reaches the body, which for effects throughout the body is counted per kilogram of body weight each day (Chapter 14). The body responds to that dose, not to the presence of a substance in a plastic. An additive that stays in the wall of a bottle is a hazard that causes no harm.
Whether the two conditions are met decides how likely harm is, and risk combines that likelihood with how severe the harm would be. ISO 14971:2019 defines risk as the "combination of the probability of occurrence of harm and the severity of that harm", in the wording of a 2025 Health Canada guidance document that reproduces it. On these definitions, a hazard can be named from the material alone, but a risk only from the device in its use, because only the use sets the route, the contact time and the patient.
One plasticizer of PVC devices shows the difference (Chapter 4). SCENIHR, a scientific committee of the European Commission, collected estimates of its dose in a 2015 opinion. On the upper estimates, the dose for adults on ECMO, a machine that oxygenates blood outside the body, is more than 200 times that for apheresis donors. Apheresis donors give blood through a machine that keeps some of its components and returns the rest. The plasticizer is therefore the same hazard in both uses, and the risks differ. The question at the head of this chapter uses "hazard" in its everyday sense. In the standard's sense, the plastic has the same hazards in a bottle and in a breathing circuit, and only its risk differs.
Five links from material to response
The two conditions sit inside a longer chain, which this book follows: the material, what leaves it or what its surface does, the route, the dose and the response. The first link is the material as made: molded, cleaned, sterilized and aged (Parts II and III). The material then offers the body either a release or a surface. The release is of molecules that diffuse out or particles that break off, and the surface is what proteins and cells meet (Chapters 4, 5 and 8). The route carries a release to tissue, and the dose measures how much arrives. The response is what the tissue does, from irritation and allergy to a capsule of scar, a clot or an effect far from the site of contact (Part IV).
Harm needs every link of the chain, so each link is a place where a device can be judged. Part V follows the links for molecules that leave a material: chemistry finds what can come out, and arithmetic estimates how much of it is tolerable and how much reaches the patient (Chapters 12 to 15). A biological test answers what that arithmetic cannot, and Chapter 18 sets out which questions those are.
The machine this book designs
Across its chapters this book designs one device, a generic home breathing machine of the kind used for obstructive sleep apnea, and calls it the running device. The running device is modeled on no single maker's design but has the parts that a machine of this type has. It blows room air at a set pressure through a hose and a mask while the patient sleeps. The air enters through an intake and a filter, and a blower with a sound-damping foam drives it. Sensors report to a controller, which runs the blower and the display. A heated humidifier warms water in a chamber and adds the water's vapor to the air. The air then travels along the hose to a nasal mask with a silicone cushion, which fabric headgear holds in place.
Machines on the market are built from the same kinds of parts, as the summaries that makers file with FDA show. One recent machine is a console with an air filter, a water tank and a heated breathing tube. Two masks have four main parts: cushion, frame, elbow and headgear. One maker's summary for a nasal mask names its materials: a polycarbonate frame, a cushion of silicone on the side that touches the face, and headgear straps of polyurethane foam, nylon and polyester. Chapter 3 takes the running device's mask from that record and chooses the materials that no summary names.
The parts on the air path share one contact and differ in the others. Every part from intake to mask touches the air the patient breathes, and together these parts form the device's gas pathway. A molecule or particle that any of them releases can therefore reach the airway. The water chamber also touches heated water. Whatever the water draws from the chamber can reach the patient in drops that condense in the hose and mask (Chapter 19). The cushion and the headgear touch the skin of the face and head for the hours of each night's use, and the housing touches the user's hands.
The patients belong to the use as well. Two makers' summaries limit their machine or mask to patients over 30 kg, and this book gives the running device the same lower limit. Because a dose for effects throughout the body is counted per kilogram of body weight, the lightest patient in the intended use receives the largest dose from any daily amount.
- The defaults. ISO 10993-17:2023, the part of the series on toxicological risk, sets default body masses. Presenters from FDA, a device maker and a toxicology consultancy cited them in 2024 slides: 60 kg for an adult woman or an adult of either sex, 3.5 kg for an infant and 0.5 kg for a neonate of very low birthweight, such as one born preterm.
- The running device. Its users weigh over 30 kg, this book's limit, and the example takes the lightest at 30 kg. From one daily amount, that user receives twice the dose per kilogram of a 60 kg adult, because 60 divided by 30 is 2.
- Smaller patients. For an infant the factor is 60 divided by 3.5, about 17, and for such a neonate 60 divided by 0.5, or 120.
- The result. With the material unchanged, one daily amount gives doses that span a factor of 120, so the patient group in the intended use is an input to the evaluation.
- Assumptions. The same daily amount reaches every patient, although a smaller patient breathes less air. The body masses are defaults, not measurements, and the slides give 50 kg or lower for the adult as the more conservative choice.
Never write "biocompatible material" in a design input; write the use beside the material. For each part, record the tissue or medium it touches, the route by which a release would reach the patient, the hours per day and the days of use, and the lightest patient in the intended use. Revisit the entries whenever a material, a process or the intended patients change.
- Biocompatibility is the ability of a material to perform with an appropriate host response in a specific application, so it belongs to a device in a use.
- One plastic would meet the body differently in a bottle, a breathing hose and a blood bag, because the contact, the route, the duration and the patient change.
- A hazard is a potential source of harm and can be named from the material, but risk depends on the route and the dose, which only the use sets, so one plastic has the same hazards in a bottle and a breathing circuit and different risks.
- This book follows the chain from material to release or surface, route, dose and response, through a home breathing machine whose parts on the air path share the breathed air and differ in their other contacts, while the headgear and the housing touch only skin.
Let's Talk